pirenzepine has been researched along with A-V Dissociation in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two cases of light-headedness or 'fainting' in patients with schizophrenia treated with olanzapine are presented." | 3.71 | A possible association between high normal and high dose olanzapine and prolongation of the PR interval. ( Kosky, N, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosky, N | 1 |
1 other study available for pirenzepine and A-V Dissociation
| Article | Year |
|---|---|
A possible association between high normal and high dose olanzapine and prolongation of the PR interval.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Electrocardiography; Heart Block; Heart Conduction Sys | 2002 |